Laboratory Medicine is Faced with the Evolution of Medical Practice
- PMID: 30564057
- PMCID: PMC6287217
- DOI: 10.1515/jomb-2017-0032
Laboratory Medicine is Faced with the Evolution of Medical Practice
Abstract
Laboratory medicine and clinical medicine are co-dependent components of medicine. Laboratory medicine functions most effectively when focused through a clinical lens. Me dical practice as a whole undergoes change. New drugs, treatments and changes in management strategies are introduced. New techniques, new technologies and new tests are developed. These changes may be either clinically or laboratory initiated, and so their introduction requires dialogue and interaction between clinical and laboratory medicine specialists. Treatment monitoring is integral to laboratory medicine, varying from direct drug measurement to monitoring cholesterol levels in response to treatment. The current trend to »personalised medicine« is an extension of this process with the development of companion diagnostics. Technological innovation forms part of modern laboratory practice. Introduction of new technology both facilitates standard laboratory approaches and permits introduction of new tests and testing strategies previously confined to the research laboratory only. The revolution in cardiac biomarker testing has been largely a laboratory led change. Flexibility in service provision in response to changing clinical practice or evolving technology provides a significant laboratory management challenge in the light of increasing expectations, shifts in population demographics and constraint in resource availability. Laboratory medicine practitioners are adept at meeting these challenges. One thing remains constant, that there will be a constant need laboratory medicine to meet the challenges of novel clinical challenges from infectious diseases to medical conditions developing from lifestyle and longevity.
Laboratorijska medicina i klinička medicina su međusobno zavisne grane medicine. Laboratorijska medicina najefiksanije funkcioniše ako deluje sa kliničkog stanovišta. Danas u celini medicinska praksa se stalno menja. Uvode se novi lekovi, postupci, kao {to se menja i upravljačka strategija. Razvijaju se nove tehnike, nove tehnologije i novi testovi. Ove promene su klinički ili laboratorijski inicirane, zbog čega njihovo uvođenje zahteva stalnu saradnju između kliničkih i laboratorijskih specijalista. Praćenje tretmana pacijenata je integralni deo laboratorijske medicine, kao npr. preko direktnog merenja leka do praćenja nivoa holesterola kao odgovora na tretman lekom. Sadašnji trend tzv. »personalizovane medicine« je odgovor na ovaj proces uz razvoj odgovarajuće dijagnostike. Tehnološka unapređenja utiču na razvoj moderne laboratorijske prakse. Uvođenje novih tehnologija potpomažu standardni laboratorijski pristupi kao i uvođenje novih testova i strategije ispitivanja koja je predhodno potvrđena u istraživačkim laboratorijama. Tako je npr. revolucija u razvoju srčanih biomarkera dovela do veklih promena u laboratorijskoj praksi. Fleksibilnost u laboratorijskom sistemu unapređuje kliničku praksu i tehnologije koje dovode do značajnih promena u sistemu upravljanja laboratorijom, a zavisno od očekivanja, demografskih promena i razvoja resursa. Zato stručnjaci u oblasti laboratorijske mdicine moraju da budu spremni da prihvate ove promene. Jedna činjenica ostaje konstantna, a to je da će uvek biti stalna potreba za laboratorijskom medicinom koja je spremna da prihvati kliničke izazove od infektivnih oboljenja do medicinskih stanja zavisno od načina i dužine života.
Keywords: analytical methods; cardiac biomarkers; drug monitoring; evidence based medicine; infection; point of care testing.
Conflict of interest statement
Conflict of interest Conflict of interest statement: The authors stated that they have no conflicts of interest regarding the publication of this article.
References
-
- Adams AJ, Banister SD, Irizarry L, Trecki J, Schwartz M, Gerona R. »Zombie« Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York. N Engl J Med. 2017;376:235. –. - PubMed
-
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Sim-vastatin Survival Study (4S) Lancet. 1994;344:1383. –. - PubMed
-
- West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996;348:1339. –. - PubMed
Publication types
LinkOut - more resources
Full Text Sources